Search Results

You are looking at 1 - 10 of 22 items for :

  • "Paraneoplastic" x
  • Refine by Access: All x
Clear All
Full access

Leena Gandhi and Bruce E. Johnson

. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors . Mod Pathol 2004 ; 17 : 222 – 229 . 5. Darnell RB Posner JB . Paraneoplastic syndromes involving the nervous

Full access

Irene Dy, Rangaswamy Chintapatla, Isabel Preeshagul, and Daniel Becker

Paraneoplastic syndromes occur in 10% to 15% of malignancies and are most often associated with carcinomas of the lung, breast, and ovary. Cancer-associated retinopathy (CAR) is a heterogenous group of paraneoplastic autoimmune disorders resulting from

Full access

Carl M. Gay, William N. William Jr, Sa A. Wang, and Thein Hlaing Oo

well-recognized paraneoplastic manifestation of thymoma. This report discusses a patient with recurrent thymoma complicated by myasthenia gravis (MG), PRCA, and AAMT several years after the initial diagnosis; both PRCA and AAMT responded successfully to

Full access

Gregory P. Kalemkerian, Wallace Akerley, Paul Bogner, Hossein Borghaei, Laura QM Chow, Robert J. Downey, Leena Gandhi, Apar Kishor P. Ganti, Ramaswamy Govindan, John C. Grecula, James Hayman, Rebecca Suk Heist, Leora Horn, Thierry Jahan, Marianna Koczywas, Billy W. Loo Jr, Robert E. Merritt, Cesar A. Moran, Harvey B. Niell, Janis O’Malley, Jyoti D. Patel, Neal Ready, Charles M. Rudin, Charles C. Williams Jr, Kristina Gregory, and Miranda Hughes

of SCLC, which results in the development of symptomatic disease between annual scans, thereby limiting the potential effect on mortality. 20 Many neurologic and endocrine paraneoplastic syndromes are associated with SCLC. 21 - 23 Neurologic

Full access

Michael W. Lew, Andres Falabella, Earl Moore-Jeffries, Russell J. Gray, and Michael J. Sullivan

: Miller RD, ed. Miller's Anesthesia, 6th ed. Oxford : Churchill-Livingstone ; 2005 . 58. Jameson JL Johnson BE . Paraneoplastic syndromes: endocrine/hematologic . In: Kasper DL, Braunwald E, Fauci A, et al. eds. Harrison's Principles

Full access

Apar Kishor P. Ganti, Billy W. Loo Jr., Michael Bassetti, Collin Blakely, Anne Chiang, Thomas A. D'Amico, Christopher D'Avella, Afshin Dowlati, Robert J. Downey, Martin Edelman, Charles Florsheim, Kathryn A. Gold, Jonathan W. Goldman, John C. Grecula, Christine Hann, Wade Iams, Puneeth Iyengar, Karen Kelly, Maya Khalil, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian Molina, Cesar Moran, Saraswati Pokharel, Sonam Puri, Angel Qin, Chad Rusthoven, Jacob Sands, Rafael Santana-Davila, Michael Shafique, Saiama N. Waqar, Kristina M. Gregory, and Miranda Hughes

for Neuroendocrine and Adrenal Tumors, at NCCN.org ). 21 , 22 Many neurologic and endocrine paraneoplastic syndromes are associated with SCLC. 23 – 25 Neurologic syndromes include Lambert-Eaton myasthenic syndrome, encephalomyelitis, and sensory

Full access

Michael D. Stubblefield, Harold J. Burstein, Allen W. Burton, Christian M. Custodio, Gary E. Deng, Maria Ho, Larry Junck, G. Stephen Morris, Judith A. Paice, Sudhakar Tummala, and Jamie H. Von Roenn

Darnell RB Posner JB . Paraneoplastic syndromes involving the nervous system . N Engl J Med 2003 ; 349 : 1543 – 1554 . 82 Berger T Malayeri R Doppelbauer A . Neurological monitoring of neurotoxicity induced by paclitaxel

Full access

Senthil Damodaran, Ewa Mrozek, David Liebner, and Kari Kendra

TC was attributed to a paraneoplastic process secondary to metastatic adenocarcinoma of the lung, and he experienced complete resolution of LV dysfunction with supportive care. 19 Recently, a case was reported of TC that occurred in a patient with

Full access

Gregory P. Kalemkerian, Wallace Akerley, Paul Bogner, Hossein Borghaei, Laura Chow, Robert J. Downey, Leena Gandhi, Apar Kishor P. Ganti, Ramaswamy Govindan, John C. Grecula, James Hayman, Rebecca Suk Heist, Leora Horn, Thierry M. Jahan, Marianna Koczywas, Cesar A. Moran, Harvey B. Niell, Janis O'Malley, Jyoti D. Patel, Neal Ready, Charles M. Rudin, and Charles C. Williams Jr.

of the aggressiveness of SCLC, which results in the development of symptomatic disease between annual scans, thereby limiting the potential effect on mortality. 22 Many neurologic and endocrine paraneoplastic syndromes are associated with SCLC. 23

Full access

Katherine Y. Fan, Avani S. Dholakia, Aaron T. Wild, Zheng Su, Amy Hacker-Prietz, Rachit Kumar, Mary Hodgin, Charles C. Hsu, Dung T. Le, Ana De Jesus-Acosta, Luis A. Diaz Jr, Daniel A. Laheru, Ralph H. Hruban, Elliot K. Fishman, Todd D. Brown, Timothy M. Pawlik, Christopher L. Wolfgang, Phuoc T. Tran, and Joseph M. Herman

that of insulin itself, and randomized trials do not confirm the increased risk associated with insulin therapy. 16 On the other hand, PDA-associated DM has been postulated to be a paraneoplastic phenomenon caused by a tumor-secreted diabetogenic